Method Development and Validation for Fingolimod by HPLC/UV in Immediate-Release Oral Capsule and Study the Effect of Excipients on Solubility and Dissolution B

Abstract

A simple, selective, linear, precise, and accurate RP-HPLC method was developed and validated for the Quantitation of Fingolimod Hydrochloride from bulk and formulations. Chromatographic separation was achieved isocratically on Zorbax Plus C 8 column (250×4.6 mm, 5μ particle size) using a mobile phase, Acetonitrile and Di-butyl ammonium phosphate buffer in the ratio of 45:55 v/v. The flow rate was 2.0 ml/min and effluent was detected at 198 and 100μl of sample was injected. Linearity was observed in the concentration range of 0.224 - 1.68 μg/ml. The percentage RSD for precision and accuracy of the method was found to be less than 2%. The method was validated according to the ICH guidelines with respect to specificity, linearity, accuracy, precision and robustness. The method developed can be used for the routine analysis of Fingolimod hydrochloride. BCS class of Fingolimod was determined by testing solubility, dissolution profile and lipophilicity by partition coefficient.

Download
Method Development and Validation for Fingolimod by HPLC/UV in Immediate-Release Oral Capsule and Study the Effect of Excipients on Solubility and Dissolution Behavior
Volume 2 Issue 1 - 2016
1Department of Pharmaceutical analysis, Dublin City University, Ireland
2Cairo University, Egypt
*Corresponding author: Islam A Osman, Department of Pharmaceutical analysis, Dublin City University, Al-Obour, Cairo, Egypt, Tel: +201003420050
Received: August 17, 2015 | Published: January 28, 2016
JAPLR-02-00008.pdf
Adobe Acrobat Document 653.9 KB